Welcome to our dedicated page for Auxly Cannabis news (Ticker: CBWTF), a resource for investors and traders seeking the latest updates and insights on Auxly Cannabis stock.
Auxly Cannabis Group Inc. reports developments as a Canadian consumer packaged goods company in the cannabis products market, with securities quoted on the OTCQB under CBWTF and listed on the TSX under XLY. Company news commonly covers quarterly and annual financial results, branded cannabis sales, product innovation, and distribution across Canadian recreational cannabis channels.
Recurring updates focus on product categories such as dried flower, pre-rolls, vapes, oils, and Cannabis 2.0 products, along with brands including Back Forty, Backpackers, and South Point. Auxly also reports capital-allocation actions, balance-sheet changes, issuer bids, debt repayment, and selective strategic financing or transaction activity tied to its cannabis portfolio.
Auxly (OTCQB: CBWTF) will report first-quarter 2026 financial results on Thursday, May 14, 2026, before markets open. Management will host a conference call and audio webcast at 10:00 a.m. EST the same day.
Dial-in access is 1-888-699-1199 (conference ID: 87366) and an audio webcast is available at the company link. A replay will be posted on the company's website within 24 hours after the call.
Auxly (OTCQB: CBWTF) filed and received TSX acceptance for a normal course issuer bid effective April 20, 2026 through the earlier of April 19, 2027 and completion of purchases. The NCIB permits repurchase and cancellation of up to 68.9 million Common Shares (less than 5% of issued shares as of April 7, 2026).
Daily purchases on the TSX are limited to 206,920 shares (based on a six‑month ADTV of 827,683). Repurchases will be funded with cash, shares bought will be cancelled, and an automatic share purchase plan is in place with a designated broker.
Auxly (OTCQB: CBWTF) said its stalking horse bid for Ayurcann was not selected, but Auxly remains the back-up bidder and will become the winning bidder if the successful bidder fails to close by May 15, 2026. Auxly provided a $2.0 million non-revolving DIP facility to Ayurcann, at 12% interest with a 2.0% upfront commitment fee and a court-ordered super-priority charge. If the sale closes, the DIP facility will be repaid and the stalking horse break fee and expense reimbursement will be paid to Auxly. Management expects significant free cash flow in 2026 and will evaluate capital allocation alternatives.
Auxly (OTCQB: CBWTF) reported 2025 results with net revenue $151.5M (+24%) and Adjusted EBITDA $43.8M (+64%). Gross Margin on Finished Cannabis Inventory Sold improved to 54%. Full-year net income was $41.9M. Year-end cash totaled $32.3M with Total Debt/Adjusted EBITDA of 1.1x. Management plans $10–12M capital spend in 2026 and became a DIP lender/stalking horse bidder for Ayurcann assets. Q4 revenue was $40.1M (+16%) with Adjusted EBITDA margin ~31%.
Auxly (OTCQB: CBWTF) reviewed 2025 milestones and issued a 2026 outlook, highlighting product innovation, distribution gains and improved financials. Key 2025 results include TTM net revenue $146M, Adjusted EBITDA $42M, and Q3 2025 net revenue of $39.9M (+20% YoY). Gross margin on finished cannabis inventory sold rose to 56% from 47% and Q3 Adjusted EBITDA reached $12.3M (31% margin). Balance sheet improvements include positive working capital $49M with $30M cash and Total Debt/Adjusted EBITDA of 1.3x (0.6x net-of-cash). Auxly plans $10–12M capex in 2026 to expand Leamington capacity and prepare for international shipments.
Auxly (OTCQB: CBWTF) reported Q3 2025 results on November 13, 2025. Key metrics: net revenues $39.9M (+20% YoY), Adjusted EBITDA $12.3M (+48% YoY, 31% margin), and net income $20.5M (+533% YoY). Gross margin on finished cannabis inventory sold improved to 56% from 47% a year earlier. Cash at quarter end totaled $30.5M (up 66% YoY). Year-to-date net revenues were $111.4M (+27%) and Adjusted EBITDA $31.2M (+99%).
The company cited higher volumes, improved pricing, manufacturing efficiencies and a gain on the Imperial Debenture settlement as drivers. Auxly plans $2.0–$2.5M of 2025 capex and to prioritize free-cash-flow-funded growth, deleveraging, and potential strategic initiatives.
Auxly Cannabis Group (OTCQB: CBWTF; TSX: XLY) will report third-quarter and nine-month 2025 results for the period ended September 30, 2025 on Thursday, November 13, 2025 before markets open.
The company's regulatory filing, press release and shareholder letter will be available on its website, and shareholders or prospective investors may contact management by the e-mail address provided by the company. The announcement is signed on behalf of the board by Hugo Alves, CEO.
Auxly Cannabis Group (OTCQB: CBWTF, TSX: XLY) announced on Oct 27, 2025 that it repaid in full a $5 million inventory loan owed to GrassHopper Capital using cash on hand. The company expects annualized interest expense savings of approximately $900,000 as a result.
Management said revenue growth and operating leverage have produced free cash flow, allowing Auxly to prioritize organic investment and strengthen the balance sheet by eliminating the loan and reducing recurring interest costs.
Auxly (OTCQB: CBWTF / TSX: XLY) will present at the Planet MicroCap Showcase: Toronto on Wednesday, October 22, 2025 at 11:30 AM EST at Arcadian Loft in Downtown Toronto.
Hugo Alves, Chief Executive Officer, will host the presentation and answer questions. A live webcast will be available via the conference platform under the event Agenda tab. Investors may register for the conference and request 1x1 meetings through the provided registration link.
Auxly Cannabis Group (TSX: XLY) held its annual general and special meeting on June 30, 2025, with 28.23% shareholder participation representing 371,890,083 common shares. All proposed matters received majority approval from shareholders.
The meeting resulted in the successful election of all nominated directors with strong support: Genevieve Young (99.39%), Hugo Alves (99.36%), Troy Grant (99.43%), Vikram Bawa (99.30%), and Conrad Tate (99.41%). Shareholders also approved the reappointment of Ernst & Young LLP as the company's auditors for fiscal year 2025.